Lukas is an ambitious entrepreneur and the driving force behind Stimvia, an innovative clinical-stage company specializing in non-invasive electroceutical treatments. He’s on a mission to make cutting-edge medical advancements accessible to all, leading the development of technology that stimulates deep brain structures to address chronic diseases like Parkinson’s and Overactive bladder, providing hope for patients with limited treatment options.

Lukas’s entrepreneurial journey began with the founding of Stimvia, which introduced a groundbreaking neurostimulation device that alleviates overactive bladder symptoms in just 12 weeks—without the side effects or invasiveness of traditional therapies. Under his leadership, the company has pushed the boundaries of neuromodulation technology, positioning itself as a global leader in the space.

Before founding Stimvia, Lukas made his mark as a transformative figure at Special Medical Technology, where he turned the company around from near collapse to thriving expansion, showcasing his unwavering commitment to healthcare innovation.

At Stimvia, Lukas continues to redefine healthcare, with the company at the forefront of treating Parkinson’s and Overactive bladder. Clinical studies confirm that Stimvia’s approach could be the most effective method available for combating this condition, offering a much-needed solution for patients around the world.

Through strategic partnerships with global leaders and participation in the prestigious Endless Frontier Labs akcelerátor. Stimvia’s innovative approach has earned the company widespread recognition, including being named one of the top 200 companies globally in the Startup Battlefield at TechCrunch Disrupt 2023, an Impact Star in the Deloitte Fast 50 2022, and Czech’s Innovation of the Year 2022. Stimvia also holds more than 120 patents worldwide, showcasing its technological leadership in the medtech space.

Lukas continues to push boundaries and reshape the future of healthcare by making advanced, patient-centric therapies accessible globally.